Prescription and Use of Paediatric Antiretroviral Drugs (ARVs) for the Treatment of HIV in Children.

Slides:



Advertisements
Similar presentations
2 nd line and recent ARVs prices and access issues Carmen Pérez Casas Access Campaign MSF May 2006.
Advertisements

Challenges to Pediatric Antiretroviral Treatment Elaine Abrams, David Hoos MTCT-Plus.
Working Group 1: Best Use ARV for Children: Principles Simplified and standardized guidelines for ARV treatment of HIV-infected children are needed to.
Group Work Recommendations-When to Start Group C.
1 M&E and ART programme Sri Lanka. 2 Overview of the presentation 1.NSACP service delivery points 2.Reporting units of ART programme 3.Recording and reporting.
Starting children and infants on ART; what do the guidelines say? Dr Siobhan Crowley Paediatric & Family HIV Care Department of HIV/AIDS World Heath Organization,
The new guidelines Dr Francois Venter Reproductive Health and HIV Research Unit University of the Witwatersrand Feb 2010.
Improving Retention, Adherence, and Psychosocial Support within PMTCT Services: Implementation Workshop for Health Workers All slide illustrations by Petra.
Dr Tin Tin Sint Department of HIV/AIDS World Health Organization
Developing child-appropriate formulations: what is in the research pipeline for paediatric ARVS? July 17, 2011 Challenges in the Development & Procurement.
P1060 commentary Philippa Musoke MBChB Makerere University –Johns Hopkins University Research Collaboration, Kampala Uganda.
ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
Case discussion part I Pediatric HIV treatment initiation รศ พญ ธันยวีร์ ภูธนกิจ หน่วยโรคติดเชื้อ ภาควิชากุมารเวชศาสตร์ คณะ แพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย.
The Role of the IATT Optimal Paediatric ARV Formulary and Considerations for New Product Introduction Nandita Sugandhi, M.D. Clinton Health Access Initiative.
Pediatric HIV Care & Treatment in Uganda A Five-Day Training Course For Health Professionals.
Wish list for design of Paediatric formulations Young Children Syrups reserve for < 10-15kg –No need refrigeration –Stability data for longstorage times,
Medicines Patent Pool – Strictly Confidential, Not for Circulation Licensing Technology and Intellectual Property for the Development of Paediatric Formulations.
KITSO AIDS Training Program
PMTCT Turning the tide together to eliminate HIV in children
DETERMINANTS OF FORECAST ACCURACY FOR PAEDIATRIC ANTIRETROVIRAL DRUGS IN KENYA NJOGO, SUSAN MUTHONI GICHUKI (U51/82556/2012)
Introduction to ARV therapy
Atieno Ojoo Technical Specialist, Pharmaceuticals
1 KITSO AIDS Training Program Lecture 5: Pediatric Specific Issues and ARV Dosing delivered by Dr. Elizabeth D. Lowenthal Botswana-Baylor Children’s Clinical.
Training course on Introducing pharmacovigilance into HIV/AIDS programmes Pretoria, South Africa, September 1-10,2004.
New and improved LPV/r based formulations for infants and young children Marc Lallemant - IAS July 1 st 2013.
Procuring High Quality ARVs at Internationally competitive Prices.
Draft WHO Pediatric ARV Guidelines Revision Summary 10/23/05 Lynne M. Mofenson, M.D. Pediatric, Adolescent and Maternal AIDS Branch National Institute.
Prevention of Mother to Child Transmission (PMTCT) of HIV
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.
Clinical Tracking and Management of HIV-Positive Children National Pediatric HIV Training 1.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
1 Antiretroviral Therapy in HIV-infected Children HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Nov 2004Access to Paediatric ARV formulations ENSURING SECURE and RELIABLE SUPPLY and DISTRIBUTION SYSTEMS in DEVELOPING COUNTRIES, in the CONTEXT OF HIV/AIDS.
Guidelines for the use of antiretroviral agents in HIV infections in Taiwan, revised in 2002 by Infectious Diseases Society of the ROC and Taiwan AIDS.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
What do we mean with ‘ there is no access to Paediatric ARV Formulations ’ ?
The Pregnancy Journey Open discussion. HIV and AIDS 2013 Romania Cumulative number people diagnosed with HIV since ,261 (of which 9,946 diagnosed.
Key1 ARV Treatment Guidelines for a Public Health Approach Product Selection for HIV Treatment Vincent Habiyambere February 2006.
Patient needs driven Research and Development Agenda in HIV Dr. Felipe Garcia de la Vega MSF Campaign for Access to Essential Medicines.
Access to Paediatric ARV Formulations Provisions for Children.
Module 3: Management of Patients on Antiretroviral Therapy Unit 2: Initiation and Monitoring of ART in Adults and Adolescents.
Agenda Introduction- Jessica Rodrigues, IATT Paediatric Treatment Optimization- George Silberry, Senior Technical Advisor for Pediatric HIV, OGAC Optimal.
Important to consider availability of child- friendly formulations Easier for HCW’s to prescribe for all ages Easier for caregivers to administer to infants.
Nov 2004Access to Paediatric ARV formulations ENSURING SECURE and RELIABLE SUPPLY and DISTRIBUTION SYSTEMS in DEVELOPING COUNTRIES, in the CONTEXT OF HIV/AIDS.
Supply Division July 2005 ENSURING SECURE and RELIABLE SUPPLY and DISTRIBUTION SYSTEMS in DEVELOPING COUNTRIES, in the CONTEXT OF HIV/AIDS and PMTCT Forecasting,
11 INTRODUCTION TO ANTIRETROVIRAL THERAPY (ART) IN CHILDREN: INITIATION AND MONITORING HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HAIVN Harvard Medical School AIDS Initiative in Vietnam
1/11/01 Pediatric trials for ARV experienced children Coleen K. Cunningham Epidemiology of treatment experience in pediatrics How does the smaller number.
PMTCT around the world Where are we? PMTCT Experts Roundtable Geneva, June 2008.
Paediatric Antiretroviral Therapy
Safe Prescribing TRUST NAME: March 2011 London Specialty School of Paediatrics and Child Health.
Optimizing the Paediatric ARV Pipeline Nandita Sugandhi Clinton Health Access Initiative &IATT CSWG ICASA 2015, Harare Zimbabwe November 30, 2015.
Safe Prescribing TRUST NAME: September 2011 Insert Specialty School of Paediatrics and Child Health.
Supporting access to quality paediatric ARVs Atieno Ojoo Technical Specialist, Pharmaceuticals UNICEF Supply Division IAS satelite session on Essential.
A MSF Newsletter of Paediatric Updates, Information, and Education The Khayelitsha Paediatric Report September, 2013 Volume 1, Number 2 Important Paediatric.
January 2006 Access to Paediatric ARV formulations Access to Paediatric ARV Formulations The plight of Children.
WHO 2013 Consultative Meeting Tawanna Hotel October 15, 2013.
The 2013 treatment guidelines and key implementation challenges Martina Penazzato IATT Normative Guidance Advisor HIV Department, WHO (Geneva, Switzerland)
SUPPLY CHALLENGES IN PROVIDING ART FOR CHILDREN: The need for responsive supply chains Naomi Printz, Technical Advisor, John Snow, Inc. Amanda Ombeva,
Antiretroviral Therapy (ART)
Justine Mirembe MD, MPH ICASA, 5th December 2011
ART 101 Successful HIV treatment usually consists of at least three drugs from two different “classes” of ARV drugs There are now six classes of ARV drugs:
Learning Objectives By the end of the session, participants will:
First-line ARV Regimens
ART Use in Selected PEPFAR Countries Forecasting for ARVs to 2010 November 7-8, 2005 Rational Pharmaceutical Management Plus.
Anthony D Harries Ministry of Health, Malawi
Group 4 Gaps & obstacles.
Presentation transcript:

Prescription and Use of Paediatric Antiretroviral Drugs (ARVs) for the Treatment of HIV in Children

Prescribing ARVs Key Questions: How do we select the appropriate regimen? How do we select the most effective ARV formulations? How do we prescribe appropriate doses of each formulation based on the child’s weight?

Three Steps to Prescribing Ped ARVs Once a child has been identified as eligible for ART and prepared to initiate treatment, there are three steps to prescribing ARVs: 1.Identify the proper regimen to prescribe based on National Guidelines and clinical condition of the child 2.Select which ARV formulations to use based on the regimen selected 3.Use the Paediatric ARV Dosing Chart to prescribe the proper amount of each formulation based on the child’s weight

Review of Regularly Used ARVs Drug ClassDrug NameAbbreviation NRTIZidovudineAZT AbacavirABC Stavudined4T Lamivudine3TC NNRTINevirapineNVP EfavirenzEFV Protease Inhibitor (PI) Lopinavir + Ritonavir LVP/r

Step 1: Identify the right regimen Select the appropriate regimen based on the national ART guidelines: AZT based regimen should always be used to initiate children on 1 st line, unless the child is anemic

Step 2: Choose the right formulations Pediatric ARVs are available in three kinds of formulations: 1.Oral suspensions i.e. AZT syrup 2. Single drug tablets i.e. 3TC 150mg 3.Fixed-dose combination tablets i.e. Triomune Baby (d4T 6mg + 3TC 30mg + NVP 50mg) 6

Step 2: Choose the right formulations AZTABCd4T3TCNVPEFVLPV/r Single Drug Formulations AZT syrup ABC syrup d4T syrup 3TC syrup NVP syrup EFV syrup LPVr syrup AZT 100mg ABC 60mg d4T 15mg 3TC 150mg NVP 200mg EFV 200mg LPVr 125mg AZT 300mg - d4T 20mg -- EFV 100mg LPVr 250mg Fixed-Dose Combinations AZT / 3TC / NVP 60/30/50mg AZT / 3TC 60/30mg ABC / 3TC 60/30mg d4T / 3TC / NVP 6/30/50mg d4T / 3TC / NVP 12/60/100mg d4T / 3TC 6/30mg d4T / 3TC 12/60mg Many different products are available to choose from…

Step 2: Choose the right formulations However, fixed-dose combinations should always be used when possible due to their many advantages over oral suspensions and single tabs: Easier to dose, as you do not have to give instructions for multiple drugs Better control in administration than oral solutions More versatile – can be crushed, dispersed in food or water, or swallowed as a tablet More neutral taste Lower tablet burden/volumes Easier to check adherence Easier to transport/store with no need for refrigeration Easier to order due to reduced number of formulations

Step 2: Choose the right formulations Fixed-dose combinations can and should be used to build every recommended regimen: Recommended Regimen Regimen using fixed-dose combinations AZT + 3TC + NVP AZT/3TC/NVP 60/30/50mg AZT + 3TC + EFV AZT/3TC 60/30mg + EFV (200mg or 100mg) AZT + 3TC + LPVr AZT/3TC 60/30mg + LPVr (solution / 125mg) ABC + 3TC + NVP ABC/3TC 60/30mg + NVP (solution / 200mg) ABC + 3TC + EFV ABC/3TC 60/30mg + EFV (200mg or 100mg) ABC + 3TC + LPVr ABC/3TC 60/30mg + LPVr (solution / 125mg) d4T + 3TC + NVP d4T/3TC/NVP 6/30/50mg d4T + 3TC + EFV d4T/3TC 6/30mg + EFV (200mg or 100mg) d4T + 3TC + LPVr d4T/3TC 6/30mg + LPVr (solution / 125mg)

Fixed-dose combination tablets can be split, crushed, and most of them dispersed in water: FormulationCan be split?Can be crushed? Can be dispersed in water? AZT/3TC/NVP 60/30/50mg AZT/3TC 60/30mg ABC/3TC 60/30mg d4T/3TC/NVP 6/30/50mg d4T/3TC 6/30mg X X

Step 2: Choosing the right formulation Fixed-dose combination tablets can be split, crushed, and most of them dispersed in water: FormulationCan be split?Can be crushed? Can be dispersed in water? AZT/3TC/NVP 60/30/50mg AZT/3TC 60/30mg ABC/3TC 60/30mg d4T/3TC/NVP 6/30/50mg d4T/3TC 6/30mg X X

Exercise 1 – Administering FDC tablets Take three fixed dose combination tablets: Split the first one in half Crush the second with a spoon Put the third in a cup and add a few MLs of water—watch it dissolve in the water Which was difficult to do? Which is easiest to teach to a mother of an HIV+ child?

Step 2: Choose the right formulation When using fixed-dose combinations, you only require the following pediatric formulations at your facility: Fixed-dose combinationsSingle formulations 1. AZT/3TC/NVP 60/30/50mg6. EFV 200mg 2. AZT/3TC 60/30mg7. EFV 100mg 3. ABC/3TC 60/30mg8. NVP solution (for use with ABC) 4. d4T/3TC/NVP 6/30/50mg9. LPVr solution 5. d4T/3TC 6/30mg10. LPVr 125mg * Will also need NVP 200mg, but that is also used for adults so should be readily available

Step 3: Prescribe the right dose The first step in dosing ARVs for children is determining the weight of the child—doses need to be increased as the child grows There are 6 major weight ranges to use when dosing: 3 – 5.9kg 6 – 9.9kg 10 – 13.9kg 14 – 19.9kg 20 – 24.9kg 25kg and above You must weigh a child each time he/she comes to the clinic to check if he/she has reached the next weight range

Step 3: Prescribe the right dose Weight ranges (kg) AZT 3TC NVP (60/30/50mg) AZT/3TC (60/30mg) adult tab ABC/3TC (60/30mg) adult tab d4t 3TC NVP (6/30/50mg) d4t/3TC (6/30mg) adult tab The number of tablets included in the table above is given twice daily Dosing of fixed-dose combinations is harmonized across drug types…

Step 3: Prescribe the right dose Dosing aide provides number of tablet to give for each formulation (including CTX) across all weight ranges:

Exercise 2:Use your Paediatric ARV Dosing Chart to answer the following about dosing FDCs: 17 1.For a 9kg child on the regimen AZT + 3TC + NVP: a.Which formulation would you use for this child? Triple FDC b. What is the average daily dose of this formulation? 1.5 BD c. How many tablets should you dispense for 30 days? 90 tablets

Exercise 2: Dosing Ped FDCs (continued) 2.For a 16kg child on the regimen ABC + 3TC + EFV: a.Which formulations would you use for this child? Dual FD of ABC + 3TC, and single dose tablet of EFV b. What is the average daily dose of these formulations? ABC/3TC 2.5 BD, 300mg of EFV c. How many tablets of each formulation should you dispense for 30 days? ABC + 3TC = 150 tablets For EFV, first need to decide on the best formulation for the patient. Is there a 300 mg tablet? NO.

Exercise 3 – Dosing syrups vs FDCs 19 You have a patient who weighs 5 kg. You prescribe a regimen of AZT/3TC/NVP. 1 st : Calculate the AM and PM dose if you were to use syrups. What is the total volume needed for a 30-day supply? AZT = 360 ml, 3TC = 180 ml, NVP = 300 ml 2 nd : Calculate the AM and PM dose if you were to use FDCs. What is the total number of tablets needed for a 30-day supply? FDC = 60 tablets

We need to consider what the patient will have to go home with…

Using FDCs for lead-in NVP dosing 21 Current recommendation for any patient initiating NVP-based ART for the first time is to dose the NVP once daily for the first two weeks to reduce risk of associated rash During 2 week lead in period, children should get the appropriate triple FDC as the AM dose, and the equivalent dual FDC for the PM dose MorningAZT/3TC/NVP EveningAZT/3TC

Exercise 4 – Lead-in dosing with FDCs 22 4 year old child Weight 12.5kg Eligible for ART Formulation? Dose? Lead-in? AZT/3TC/NVP 60/30/50mg 2 am / 2 pm Initiate lead- in for 2 weeks 28 tabs of triple FDC, 28 tabs of dual FDC Initiate full ART 120 tabs of triple FDC Follow up 120 tabs of triple FDC until weight increases to 15kg

Case Study Practice Let’s examine a few real cases and correctly determine: – What regimen should they be given? – What formulations should you use? – How much would you prescribe of each formulation?

Case 1 Osofia is 3 month old and weighs 5 kg. She was given single dose NVP for PMTCT but went on to get HIV infected. Currently you don’t have kaletra syrup at your facility. Initiate the patient on treatment in the recommended way. What regimen should she be given? AZT/3TC/NVP What formulations should you use? Triple FDC of AZT/3TC/NVP and Duo fixed dose AZT/3TC How much would you prescribe of each formulation? Triple FDC AZT/3TC/NVP-1 od and AZT/3TC 1 od If you are giving them a 14-day supply, how many tablets should you give them of each formulation? AZT/3TC/NVP 14 tablet and AZT/3TC -14 tablets

Case 2 IBU is a 6 month old infant who is HIV positive. He received NVP syrup for prophylaxis. He is not anemic and the weight is 6 kg. You have all the drugs available in the facility. What regimen should they be given? AZT/3TC/Kaletra What formulations should you use? FDC- AZT/3TC and Syrup for kaletra How much would you prescribe of each formulation? AZT/3TC- 1.5 BD and Kaletra 1.5 mls BD If you are giving them a 30-day supply, how many tablets should you give them of each formulation? AZT/3TC 90 tablets and Kaletra 90mls for 30 days

Case 3Mary is 4 years old and weighs 15 kg. She was diagnosed with HIV. She is anemic and you don’t have abacavir in your facility. What criteria would you use to determine if Mary is eligible for ARVs? CD4 %- less than 25% or CD count <750 or WHO clinical stage 3 or 4 If she is eligible for ARVs What regimen should she be given? D4T/3TC/NVP What formulations should you use? Triple FDC of D4T/3TC/NVP baby and Duo FDC D4T/3TC baby How much would you prescribe of each formulation? D4T/3TC/NVP 2.5 A.M. and D4T/3TC 2.5 P.M. If you are giving her a 14-day supply, how many tablets should you give her of each formulation? D4T/3TC/NVP 35 tablets and D4T/3TC 35 tablets If she comes back for after 14 days as she has tolerated the drugs what formulation would you give, what dose and how many tablets would you dispense for 30 days? D4T/3TC/NVP baby, 2.5 BD and 150 mg

Case 4 Aki is a 7 year old HIV positive boy. He is anemic and is eligible to start ARV’s. You have abacavir in you facility. He is 18 kg. What regimen should they be given? ABC/3TC/NVP or ABC/3TC/EFV What formulations should you use? Duo FDC for ABC/3TC and single tablets NVP or Duo FDC ABC/3TC and single tablet EFV How much would you prescribe of each formulation? ABC/3TC 2.5 BD and Tab NVP 1 in morning and 0.5 in Evening Or ABC/3TC 2.5 BD and Tab EFV(600mg) 0.5 mg od If you are giving them a 30-day supply, how many tablets should you give them of each formulation? ABC/3TC 150 tablets and NVP 45 tablets Or ABC/3TC 150 tablets and EFV 15 tablets

Case 5 Popo is a 9 year old boy who is HIV+. He is not on ARVs and was diagnosed with TB. His weight is 21kg. He is eligible to start ARVs. When would you start him on ARVs 2-8 weeks after initiation of anti TB treatment What regimen should they be given? AZT/3TC/EFV What formulations should you use? Dou FDC AZT/3TC and single tablet EFV How much would you prescribe of each formulation? AZT/3TC 3BD and EFV (600mg) 0.5 od If you are giving them a 30-day supply, how many tablets should you give them of each formulation? AZT/3TC 180 tablets and EFV(600mg) 15 tablets

Summary Use the national ART guidelines to select which regimen to use – Always check for anemia to determine if AZT is acceptable When selecting formulations, always use fixed-dose combinations where possible – Easier to dose and better for the patient Always take the child’s weight, and use the Ped ARV dosing chart to determine how much to prescribe of each formulation